1. Introduction {#sec1}
===============

Each year 2.4 million Americans are hospitalized for acute coronary syndrome (ACS) \[[@B1]\]. Growing evidence supports that post-ACS depression is an independent risk factor for future cardiac events and mortality \[[@B2]--[@B4]\], and females are disproportionately affected \[[@B5]\]. An estimated 7.5 million females live with a history of ACS \[[@B1]\] and up to 47% of females report symptoms of depression when screened for depression during hospitalization for ACS \[[@B6]\]. Depression is the most common mental illness in females and females have twice the risk of major depressive disorder (MDD) as compared with males \[[@B7], [@B8]\]. Data from National Comorbidity Survey (NCS) supports the gender difference life time risk for MDD (21% in females and 13% in males) \[[@B9]\]. Population studies from Canada \[[@B10]\], Germany \[[@B11]\], and Switzerland \[[@B12]\] all report that females are at least twice as likely as males to suffer from MDD. In addition to the gender difference in prevalence of depression episodes, the depression symptoms that differ between males and females are heterogeneous with complex clusters of depressive symptoms \[[@B13], [@B14]\].

Data from large epidemiological studies reveals that males and females often report distinct differences in the self-reported somatic depressive symptoms of depression \[[@B15]--[@B17]\]. Somatic depressive symptoms include sleep disturbance, appetite disturbance, and fatigue for at least two weeks \[[@B15]--[@B17]\]. Silverstein interviewed college students and found that female students had higher somatic depressive symptoms than male students \[[@B18]\]. Self-reported data from NCS also indicated that females reported twice the frequency of somatic depression symptoms as compared to males \[[@B19]\]. Although higher rates of depression have been reported in patients with ACS, no known studies have specifically evaluated gender differences in specific depressive symptoms reported during the ACS event. The purpose of this study was to examine the gender differences and prevalence of self-reported depressive symptoms and self-reported somatic depressive symptoms, as measured by the Beck Depression Inventory II (BDI-II) \[[@B20]\], in patients hospitalized for ACS.

2. Methods {#sec2}
==========

This was a cross-sectional observational study with a convenience sample of 789 adults (248 females and 541 males) hospitalized for ACS. The study included all participants meeting the inclusion criteria of a larger study looking at the interactions of genetics and depression on ACS outcomes. The overall rate for males verses females was consistent with the gender ratio for ACS admitted to the facility. Participants were recruited during hospital admission for ACS and were screened for self-reported depressive symptoms, by trained research nurses, using the BDI-II. Depression was defined as a BDI-II score of ≥14 indicating at least moderate symptoms of depression \[[@B20]\].

The study was approved by the University\'s Committee for the Protection of Human Subjects Internal Review Board. After informed consent was obtained, by trained research nurses, the BDI-II was administered when the patients were stable enough during their hospital stay to answer the questions (1--3 days after hospital admission). Inclusion criteria consisted of a confirmed diagnosis of ACS and 18 years of age or older. ACS was defined as chest pain or symptoms suggestive of ACS lasting for more than 15 minutes with new transient or persistent ST-wave ischemic electrocardiogram (ECG) changes and ultimate disposition as (1) acute myocardial infarction (AMI), including ST-wave elevation infarction and non-ST wave elevation infarction or (2) unstable angina \[[@B19]\]. The final ACS diagnosis was verified through their hospital inpatient medical records.

The BDI-II is a reliable and well-validated 21-item depression screening scale that uses a forced-choice 4-alternative response format that has been used in the ACS population \[[@B20]\]. The BDI-II has been used for 35 years to identify and assess depressive symptoms and reports high reliability (.80) regardless of the population \[[@B21], [@B22]\]. The construct validity of BDI-II has been established and has shown to be able to differentiate between depressed and non-depressed individuals. Higher coefficient alphas (.92 for outpatients and  .93 for college students) have been reported for the BDI-II when compared to the previous version of the Beck Depression Inventory (BDI) \[[@B22]\]. Test-retest reliability was studied with baseline data obtained on 26 outpatients and therapy sessions one week apart (correlation  .93, *P* \< 0.001) \[[@B22]\]. The internal consistency of the BDI-II in patients with ACS has an alpha value of 0.87 \[[@B23]\]. Higher BDI-II scores indicate a greater number of depressive symptoms. BDI-II scores of ≥14 indicate a moderate level of depressive symptoms \[[@B20], [@B24]\]. This cut-off score has successfully been used to screen patients hospitalized for ACS (odds ratio, 7.82; 95% CI, 2.42 to 25.26; *P* = 0.0002) and the internal consistency of the BDI-II in patients with ACS has an alpha value of 0.87 \[[@B24]\].

Somatic depressive symptoms were measured using BDI-II question 16 (sleep disturbance), question 18 (appetite disturbance), and question 20 (fatigue). A patient was identified as positive for somatic depressive symptoms when the patient rated all three items as 1 or above. If a patient rated 0 on any of the three items, he or she was categorized as negative for somatic depressive symptoms. Pearson chi-square tests for independence (categorical variables) or *t*-tests for independent samples (continuous variables) were used to examine differences in demographic characteristics between males and females. Comparisons of depression ordinal scores and symptoms by gender were conducted with Wilcoxon rank sum and Pearson chi-square tests for independence, respectively. Degrees of freedom for the Pearson chi-square test were defined as follows: (*r* − 1) × (*c* − 1), where *r* = the number of rows and *c* = the number of columns. Significance level was set at *P* \< 0.05. Data were analyzed using SAS 9.2 statistical software.

3. Results {#sec3}
==========

3.1. Baseline Characteristics {#sec3.1}
-----------------------------

The sample consisted of 789 adult (248 females and 541 males) patients admitted with ACS ([Table 1](#tab1){ref-type="table"}). Ages ranged from 28 to 96 years. A total of 88 (35%) females and 120 (22%) males had BDI-II scores of 14 or higher. Sixty percent of the patients were hospitalized for their first ACS event. The majority of the patients were Caucasian males (64%), with a mean age of 61.35 years (S.D. = 11.56). A significantly higher percentage of females were not married (51% for females and 27% for males, *P* \< 0.0001), lived alone (25.5% for females and 17.6% for males, *P* = 0.0098), and were less physically active (35% for females and 24% for males, *P* = 0.0002) than males. More than half of females in the study had less than high school education (52%, *P* \< 0.0001), while the majority of males had at least some college or college degree (60%). Females were more likely to currently be taking antidepressants (21.3%) than males (10.57%) (*P* \< 0.0001) and significantly more females (31.7%) than males (16.3%) (*P* \< 0.0001) reported a history of depression diagnosis or treatment.

3.2. Prevalence of Self-Reported Depressive Symptoms {#sec3.2}
----------------------------------------------------

Results showed that depression during ACS episodes are different between males and females. Significantly more females (43.5%) reported feeling depressed over the past year than compared to males (27.2%). During admission for ACS, the average BDI-II scores were significantly higher for females (mean = 11.89, S.D. = 9.68) than that for males (mean = 9.00, S.D. = 7.93) (*P* \< 0.0001) indicating that the females reported greater depressive symptoms. Females reported significantly more sadness, self dislike, crying, indecisiveness, sleep disturbance, appetite disturbance, and loss of interest in sex than males ([Table 2](#tab2){ref-type="table"}). Significantly more females (7.66%) were identified as positive for somatic depression symptoms (reported 1 or higher scores on all three questions) than males (2.22%) (*P* = 0.0003).

4. Discussion {#sec4}
=============

The prevalence of depression in this study was significantly higher in the females (35%) than males (22%) (BDI-II scores ≥ 14). Of the 21 depressive symptoms evaluated by the BDI-II, 19 depressive symptoms were reported more frequently by females; 7 out of the 19 symptoms reaching statistical significance (*P* \< 0.05). Although our results support the increase in somatic symptoms in females (sleep and appetite disturbances), as reported by Wenzel \[[@B15]\], self-reported symptoms of fatigue were not statistically different between males and females.

Several methodological caveats must be considered when interpreting the data. The sample was a convenient sample largely made up of Caucasians with a high number of males, and participants were recruited from two large tertiary medical centers with high levels of acuity. Although similar patterns of somatic depressive symptoms have been reported from several epidemiological studies \[[@B15]--[@B17]\], other comorbid psychiatric, medical conditions, and treatments that may affect somatic symptoms should be considered. Some of the self-reported somatic symptoms may have been caused by the current ACS event. Despite these limitations, results from this study raise the possibility that females may have heterogeneous symptomology with various depression subtypes that may affect their morbidity and mortality after ACS events.

5. Conclusion {#sec5}
=============

In conclusion, results from the present study support the hypothesis that there are gender differences in depression prevalence and self-reported somatic depressive symptoms, in patients hospitalized for ACS. Somatic symptoms may be important indicators of depression among ACS patients, especially female patients. The ability to diagnose and treat depression in these patients is an important intervention that would decrease subsequent ACS events. Future studies are needed to identify the biological and psychological mechanisms to explain this gender difference.
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###### 

Comparison of demographic and clinical health characteristics of acute coronary syndrome patients.

  Variables                                       (*n* = 789)     Women (*n* = 248)   Men (*n* = 541)   *P* value
  ----------------------------------------------- --------------- ------------------- ----------------- ------------
  Age at consent                                                                                        0.0013\*
   M (year) ± SD                                  62.28 ± 12.03   64.31 ± 12.79       61.35 ± 11.56     
   Range                                          28--96          29--96              32--95            
  BMI                                                                                                   0.2995
   M (lb/inch^2^) ± SD                            30.13 ± 6.44    30.53 ± 7.91        29.95 ± 5.64      
   Range                                          16.47--58.57    16.47--61.33        18.09--58.57      
  BDI Score (0--63)                                                                                     \<0.0001\*
   M ± SD                                         9.93 ± 8.63     11.98 ± 9.68        9.00 ± 7.93       
   Range                                          0--48           0--48               0--43             
  Race                                                                                                  0.0274\*
   White                                          485 (61.47)     141 (56.85)         344 (63.59)       
   Black                                          152 (19.26)     63 (25.40)          89 (16.45)        
   Spanish/Hispanic Latino Descent                123 (15.59)     37 (14.92)          86 (15.90)        
   Some other race                                29 (3.68)       7 (2.82)            22 (4.07)         
  Marital Status                                                                                        \<0.0001\*
   Single, Divorced, Separated, Widowed           272 (34.56)     126 (51.01)         146 (27.04)       
   Married                                        515 (65.44)     121 (48.99)         394 (72.96)       
  Living arrangement                                                                                    0.0098\*
   Live with spouse or family member              630 (79.95)     184 (74.49)         446 (82.44)       
   Live alone                                     158 (20.05)     63 (25.51)          95 (17.56)        
  Education                                                                                             \<0.0001\*
   ≤High school                                   340 (43.26)     129 (52.23)         211 (39.15)       
   Some college/vocational Technical              217 (27.61)     74 (29.96)          143 (26.53)       
   College degree and above                       229 (29.13)     44 (17.81)          185 (34.32)       
  Smoking                                                                                               0.0054\*
   Yes, currently                                 178 (22.62)     54 (21.77)          124 (23.01)       
   Yes, but quit (≤1 year)                        290 (36.85)     74 (29.84)          216 (40.07)       
   Never                                          319 (40.53)     120 (48.39)         199 (36.92)       
  Alcohol                                                                                               \<0.0001\*
   Yes, currently                                 364 (46.43)     87 (35.22)          277 (51.58)       
   Yes, but quit (≤1 year)                        87 (11.10)      14 (5.67)           73 (13.59)        
   Never                                          333 (42.47)     146 (59.11)         187 (34.82)       
  Activity                                                                                              0.0002\*
   More active                                    354 (45.10)     86 (34.82)          268 (49.81)       
   Less active                                    218 (27.77)     88 (35.63)          130 (24.16)       
   About same                                     213 (27.13)     73 (29.55)          140 (26.02)       
  Depressed (BDI ≥14)                             208 (26.36)     88 (35.48)          120 (22.18)       0.0001\*
  Depression questions                                                                                  
   Current antidepressant use                     108 (13.95)     52 (21.31)          56 (10.57)        \<0.0001\*
   History of Depression feeling                  251 (32.39)     107 (43.50)         144 (27.22)       \<0.0001\*
   History of depression diagnosis or treatment   164 (21.19)     78 (31.71)          86 (16.29)        \<0.0001\*

Note: values in parenthesis are percentages.

\*Statistical significant at level of *P* \< 0.05.

###### 

Proportional comparison of each individual BDI-II question.

  BDI-II 21 questions symptom present ≥1   All (*n* = 789)   Females (*n* = 248)   Males (*n* = 541)   *P* value
  ---------------------------------------- ----------------- --------------------- ------------------- ------------
  Q1:Sadness                               206 (26.14)       91 (36.69)            115 (21.30)         \<0.0001\*
  Q2:Pessimism                             245 (31.05)       86 (34.68)            159 (29.39)         0.1362
  Q3:Past failure                          174 (22.08)       65 (26.21)            109 (20.19)         0.0583
  Q4:Loss pleasure                         330 (41.83)       103 (41.53)           227 (41.96)         0.9101
  Q5:Guilty feelings                       217 (27.57)       79 (31.98)            138 (25.56)         0.0611
  Q6:Punish feelings                       95 (12.09)        33 (13.36)            62 (11.50)          0.4583
  Q7:Self dislike                          149 (18.93)       59 (23.98)            90 (16.64)          0.0147\*
  Q8:Self criticalness                     235 (29.90)       72 (29.15)            163 (30.24)         0.7564
  Q9:Suicidal whish                        47 (5.96)         19 (7.56)             28 (5.18)           0.1708
  Q10:Crying                               186 (23.66)       90 (36.59)            96 (17.78)          \<0.0001\*
  Q11:Agitation                            356 (45.12)       117 (47.18)           239 (44.18)         0.4318
  Q12:Loss of interest                     235 (29.78)       79 (31.85)            156 (28.84)         0.3893
  Q13:Indecisiveness                       193 (24.49)       76 (30.77)            117 (21.63)         0.0056\*
  Q14:Worthless                            136 (17.24)       52 (20.97)            84 (15.53)          0.0603
  Q15:Loss of energy                       579 (73.38)       193 (77.82)           386 (71.35)         0.0561
  *Q16:Sleep disturbance*                  453 (57.41)       156 (62.90)           297 (54.90)         0.0348\*
  Q17:Irritability                         295 (37.44)       100 (40.32)           195 (36.11)         0.2566
  *Q18:Appetite disturbance*               313 (39.67)       121 (48.79)           192 (35.49)         0.0004\*
  Q19:Concentration                        330 (41.83)       115 (46.37)           215 (39.74)         0.0797
  Q20:Fatigue                              565 (71.61)       189 (76.21)           376 (69.50)         0.0523
  *Q21:Loss Interest Sex*                  323 (41.09)       128 (51.82)           195 (36.18)         \<0.0001\*

Note: values in parenthesis are percentages and BDI-II symptoms are considered present with a BDI-II score ≥1 in 0--3 scoring system.

\*Statistical significant at level of *P* \< 0.05.
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